Inventor · disambiguated record
Richard Kolesnick
Also filed as: KOLESNICK RICHARD · KOLESNICK RICHARD N
23 granted patents·17 pending applications·52 citations·filing 1992–2025
94Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER18SLOAN KETTERING INST CANCER5SLOAN KETTERING INST CANCER RES5KOLESNICK RICHARD N4ROTOLO JIMMY ANDREW3
Top patents by PatentIndex Score
40 records- 0189US2025325559A1Methods for treating gi syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2024·Application pending·0 cites
- 0287US10450385B2Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Oct 22, 2019·3 cites·4 claims
- 0385US2025197524A1Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0483US12214218B2Perfusion modulated tumor dose sculpting with single dose radiotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Feb 4, 2025·2 cites·20 claims
- 0582US10975169B1Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Apr 13, 2021·2 cites·19 claims
- 0682US8562993B2Methods for treating GI syndrome and graft versus host diseaseROTOLO JIMMY ANDREW·Filed 2008·Granted Oct 22, 2013·4 cites·6 claims
- 0782US2025144086A1Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0880US12121525B2Methods for treating GI syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2021·Granted Oct 22, 2024·0 cites·4 claims
- 0978US11207329B2Methods for treating GI syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2018·Granted Dec 28, 2021·1 cites·6 claims
- 1078US7301017B2Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesisKOLESNICK RICHARD N·Filed 2003·Granted Nov 27, 2007·7 cites·28 claims
- 1178US2023416409A1Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1276US12036212B2Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 1375US11447572B2Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Sep 20, 2022·0 cites·13 claims
- 1474US10413533B2Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Sep 17, 2019·1 cites·10 claims
- 1572US9592238B2Anti-ceramide monoclonal antibody 2A2ROTOLO JIMMY ANDREW·Filed 2013·Granted Mar 14, 2017·1 cites·8 claims
- 1670US11285137B2Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Mar 29, 2022·0 cites·26 claims
- 1770US7850984B2Protection of the female reproductive system from natural and artificial insultsGEN HOSPITAL CORP·Filed 2002·Granted Dec 14, 2010·2 cites·27 claims
- 1870US2021069330A1Methods and compositions for tumor radiosensitizationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 1969US7195775B1Protection of the female reproductive system from natural and artificial insultsGEN HOSPITAL CORP·Filed 2000·Granted Mar 27, 2007·1 cites·17 claims
- 2065US2018015183A1Method and composition to increase radiation-induced tumor therapeutic effectsMEMORIAL SLOANE-KETTERING CANCER CENTER·Filed 2017·Application pending·0 cites
- 2165US2007157331A1Protection of female reproductive system from natural and artifical insultsMASSACHUSETTS GEN HOSPITAL·Filed 2007·Application pending·0 cites
- 2261US10722577B2Methods for treating GI syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2013·Granted Jul 28, 2020·0 cites·9 claims
- 2359US2022118087A1Methods for treating gi syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2020·Application pending·0 cites
- 2459US2017007718A1Method and composition to increase radiation-induced tumor therapeutic effectsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Application pending·0 cites
- 2558US8283459B2Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesisKOLESNICK RICHARD N·Filed 2007·Granted Oct 9, 2012·0 cites·11 claims
- 2658US2017273987A1Methods for Treating GI Syndrome and Graft versus Host DiseaseROTOLO JIMMY ANDREW·Filed 2017·Application pending·0 cites
- 2757US8258108B2Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesisKOLESNICK RICHARD N·Filed 2007·Granted Sep 4, 2012·0 cites·18 claims
- 2857US7528116B2Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesisSLOAN KETTERING INST CANCER·Filed 2003·Granted May 5, 2009·3 cites·30 claims
- 2957US6790627B2Methods and compositions for the modulation of acid-sphingomyelinase-related apoptosisSLOAN KETTERING INST CANCER·Filed 2001·Granted Sep 14, 2004·1 cites·10 claims
- 3057US2025367471A1Perfusion modulated tumor dose sculpting with single dose radiotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 3155US6274309B1Method for the modulation of acid-sphingomyelinase-related apoptosisFiled 1996·Granted Aug 14, 2001·9 cites·9 claims
- 3255US5451518APurified human ceramide-activated protein kinaseSLOAN KETTERING INST CANCER·Filed 1992·Granted Sep 19, 1995·10 cites·1 claims
- 3355US2012252883A1Method and Composition to Increase Radiation-Induced Tumor Therapeutic EffectsKOLESNICK RICHARD N·Filed 2010·Application pending·0 cites
- 3453US2022348678A1Methods and compositions for treating diabetic retinopathyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 3552US2024158487A1Wound healing enhancement with anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 3650US2014205543A1Method for diagnosing or treating tumors using sphingomyelin containing liposomesSLOAN KETTERING INST CANCER·Filed 2014·Application pending·0 cites
- 3749US10052387B2Ceramide reversal of multi-drug resistanceMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Aug 21, 2018·0 cites·19 claims
- 3849US2023167197A1Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3943US2018015184A1Method and composition to increase radiation-induced tumor therapeutic effectsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 4035US6040149AAssay for identifying agents which act on the ceramide-activated protein kinase, kinase suppressor of ras, and methods of using said agentsSLOAN KETTERING INST CANCER·Filed 1997·Granted Mar 21, 2000·5 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Richard Kolesnick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →